Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin condition...
Top Biotech Gainers: WGRX Rebrands, PVLA Nears FDA Milestone, ASBP On Track For NDA Filing
Opaleye Management reports $124,893 Sol-Gel Technologies share purchase
Major Investor Quietly Boosts Stake in Sol-Gel Technologies
Opaleye Management reports $38,433 Sol-Gel Technologies share acquisition
Major Investor Quietly Boosts Position in Sol-Gel Technologies
Opaleye Management reports $123,073 Sol-Gel common share purchase